ANIP – ani pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
3/12
09:32 am
anip
Low
1 Growth Stock to Target This Week and 2 to Avoid [Yahoo! Finance]
3/12
07:22 am
anip
Low
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $85.00 price target on the stock.
3/6
07:08 pm
anip
Low
ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]
3/6
01:18 pm
anip
Low
ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
3/5
09:56 am
anip
Low
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Guggenheim from $84.00 to $86.00. They now have a "buy" rating on the stock.
2/28/2025
06:50 am
anip
11.4%
BEAT
2/28/2025
06:50 am
anip
4.0%
BEAT
2/28/2025
06:50 am
anip
-0.1%
BEAT
2/28/2025
06:50 am
anip
4.9%
BEAT
3/12
09:37 am
Initiates
Overweight
JP Morgan
Low
1.7%
3/12
07:22 am
Initiates
Overweight
JPMorgan Chase & Co.
Low
1.9%
3/12
05:07 am
Initiates
OVERWEIGHT
JPMORGAN
Low
2.0%
3/5
09:33 am
Maintains
Buy
Buy
Guggenheim
Low
2.7%
3/5
09:33 am
Maintains
Buy
Buy
Guggenheim
Low
2.7%
3/11
07:01 am
anip
Medium
Form 8-K ANI PHARMACEUTICALS INC For: Mar 11
3/10
08:28 pm
anip
Medium
Form 4 ANI PHARMACEUTICALS INC For: Mar 07 Filed by: Davis Krista
3/7
04:09 pm
anip
Low
Form 4 ANI PHARMACEUTICALS INC For: Mar 05 Filed by: Gutwerg Ori
3/4
05:15 pm
anip
Low
Form 4 ANI PHARMACEUTICALS INC For: Feb 28 Filed by: Rowland Thomas Andrew
3/4
05:12 pm
anip
Low
Form 4 ANI PHARMACEUTICALS INC For: Feb 28 Filed by: Mutz Christopher
Show more
Top News Gainers
3/24 ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL 18.7%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
Top News Decliners
11/6 Q3/2019 9/30/2019 EPS 1.230 ZacksConsensus 1.320 ActVsEst (0.090) - Miss -23.7%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3